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Aim of the study: To investigate the effect of the Inerventions method on gross motor
function in children with spastic cerebral palsy (CP).
Clinical rationale for the study: The Inerventions method is the type of transcutaneous
electrical nerve stimulation (TENS) delivered through a full-body garment (Mollii suit) that
aims to prompt reciprocal inhibition via the antagonist to reduce spasticity in selected
muscle groups. Although Mollii is approved by the European Union as a medical device,
independent clinical tests have not yet been performed.
Materials and methods: 16 children with spastic CP, aged [104_TD$DIFF] .7  1.3 were recruited and then
willingly assigned to the Inerventions method (n [105_TD$DIFF] = 8) and control groups (n [106_TD$DIFF] = 8). In the
Inerventions method group, TENS was applied [107_TD$DIFF] h per session, 3 days weekly for 3 weeks.
Children of the control group received functional exercises program for the same duration,
frequency and length. Outcome measures included the Gross Motor Function Measure,
passive range of motion (PROM), the Modiﬁed Tardieu Scale, and the Timed Up and Go test.
Results: While both groups experienced improvements in grossmotor function andmobility,
the difference in improvement between children treated with the TENS and physiotherapy
did not reach statistical signiﬁcance. No change occurred in PROM and spasticity in either
group following the interventions.
Conclusions: There is no superior efﬁcacy of the Inerventions method compared to conven-
tional physiotherapy.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.1. IntroductionCerebral palsy (CP) is a non-progressive neurological disorder
that affects muscle tone, posture, movements and motor
skills. The motor disorders of CP are often accompanied by
disturbances of sensation, cognition, communication,* [103_TD$DIFF]Corresponding author.
E-mail address: bakind@gmail.com (I. Bakaniene).
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0028-3843/© 2018 Polish Neurological Society. Published by Elsevier Sperception, behaviour, and seizure disorder [1]. Various
therapeutic interventions have been developed for children
with CP as well as their family members. Novak at al. (2013) in
the systematic review have selected interventions that are
evidence based: medications (botulinum toxin, diazepam,
anticonvulsants, bisphosphonates), therapies (casting, hip
surveillance, constraint-induced movement therapy, biman-p. z o.o. All rights reserved.
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al training, occupational therapy following botulinum toxin,
home programmes, ﬁtness, and pressure care), and surgery
(selective dorsal rhizotomy). Some other interventions, in-
cluding electrical stimulation (ES), were attributed to the group
of therapies with uncertain effect [2].
ES is a therapeutic treatment that applies an electrical
current to stimulate nerves and muscles. If proved effective it
might provide an alternative to stretching and strengthening
exercises techniques for children with CP, or indeed it might
improve treatment compliance in those children who ﬁnd
exercise programmes difﬁcult. Unfortunately, lack of consen-
sus on optimal treatment parameters and methods of
delivering ES as well as unconvincing research data limits
the use of this intervention in clinical practice [3]. Neverthe-
less, interest in the area of CP and ES is growing because it has
potential as passive, non-invasive, home-based therapy [3,4].
There are two types of ES that can be used in clinical
practice: functional ES (FES) and threshold ES (TES). FES is the
application of an electrical current of sufﬁcient intensity to
elicit muscle contraction. Alternatively, TES is described as a
low-level, sub-contraction ES.
A growing number of mainly small studies tend to support
that the use of FES is beneﬁcial and can lead to improvement in
both gross motor function and mobility for children with CP.
However, these ﬁndings must be interpreted with caution
because of insufﬁcient statistical power and other methodo-
logical limitations of the FES studies [3,4].
The application of TES for children with CP is even more
questionable. There is relatively little research on the effects of
TES, and the results of the studies are inconsistent. Pape et al.
(1993) reported that leg muscles TES improved gross motor,
locomotor, and receipt/propulsion skills for children with
spastic diplegia [5]. Hazlewood et al. (1994) have found positive
effect of TES on passive range of movement of the ankle and
knee for children with spastic hemiplegia [6] while Steinbok
et al. (1997) described thepositive effect of TES onmotor abilities
of children with CP who had undergone selective posterior
lumbosacral rhizotomy [7]. In addition, the study of Liron-
Keshet et al. (2001) revealed that TES has improved gait quality
and range of motion for children with diplegic CP [8]. However,
studies by Sommerfelt et al. (2001), and Dali et al. (2002) have
failed to ﬁnd a statistically signiﬁcant effect of TES on motor
function in children with CP [9,10].Contradictory results of TES
studies may be explained by differences in TES application
methods and/or methodological limitations of the studies: a
small sample size [6,8] and/or uncontrolled study design [5,6].
Since 2010, another method of delivering TES, so called the
Inerventions method was developed as a new and reﬁned
strategy for treating patients with spasticity. The principle of
this method is based on mild, low frequent ES which prompts
reciprocal inhibition via the antagonist to relax spasticity in
selected muscle groups [11]. Electrical rehabilitation suit, so
called Mollii, was designed to provide this type of ES.
2. Clinical rationale for the studyAlthough Mollii is approved by the European Union as a
medical device, independent clinical tests have not yet beenperformed. Its use has been growing in Sweden since 2010 and
in Europe since 2012 [12], so there is considerable demand for
research on the beneﬁts of this method.
Therefore,wehavedecided to conduct a study to determine
whether the Inerventions method would improve passive
range of motion (PROM), spasticity, motor function, and
mobility in children with spastic CP.3. Material and methods
Pre/post cohort study with a conventional therapy control
group was conducted between September 2016 and December
2016. Ethical approval was granted by the Kaunas Regional
Biomedical Research Ethics Committee (registration number
BIC – SR (M) – 60). Since all of the children in this study were
younger than 18 years, informed consent was obtained from
the parents of the children who agreed to participate in this
study.
3.1. Participants
Children with spastic CP were recruited for the study from the
Children Rehabilitation Department according to the inclusion
and exclusion criteria. Inclusion criteria necessitated that
children: (1) have the diagnosis of spastic CP; (2) be between
the ages of 3 and 9 years; (3) be able to walk with or without
support; (4) be able to accept and follow verbal instructions,
and cooperate with therapeutic programming. Children were
excluded from participation in the study if they had a
ventriculoperitoneal shunt or a cardiac stimulator, o if they
demonstrated uncontrolled epilepsy or behavioural disorders.
Based on the review of medical records of the Children
Rehabilitation Department a total of 42 children were
potentially eligible to participate in the study. One of the
researchers made telephone calls to parents of all eligible
participants in order to provide information about the study,
answer any possible questions concerning the study, exclude
potential participants who did not fulﬁl the inclusion criteria,
and to ask for possible reasons if participation was declined.
Parent's reasons for their children not participating in the
study included: not wishing to use time on any trial
participation; not having vitality, strength or energy to
participate in an extensive study; being unwilling to have
their child undergo non-evidence based treatment. In total 16
ambulatory children with spastic CP (10 unilateral, 6 bilateral:
8 girls and 8 boys), aged 3–9 years (mean [108_TD$DIFF]4.6  1.3 years) whose
GMFCS level was I, II or III (GMFCS level I/II/III: 9/6/1)
participated in this study.
3.2. Procedure
The children were willingly assigned into the experimental (n[109_TD
$DIFF] = 8) and the control (n = 8) groups. Attempts were made to
match groups based on demographic characteristics. Children
of the experimental group were given skeletal muscle ES
(antagonist to the spastic muscle) at a frequency of [110_TD$DIFF]20 Hz, a
pulse width from 25 to [111_TD$DIFF] 75 ms, and the voltage from 3 to [112_TD$DIFF] 0 V
depending on the child's age. ES was delivered to the
quadriceps and/or the ankle dorsiﬂexors according to the
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applied [107_TD$DIFF] h per day, 3 times a week over a three weeks period.
When wearing the Mollii suit, children were playing table
games and interacting with peers and parents. The control
group received conventional strengthening and stretching
exercises [107_TD$DIFF] h per day, 3 times a week over a three week period.
Both ES and physiotherapy sessions were conducted in a
physiotherapy room at the Children's Rehabilitation Depart-
ment. Considering our intervention protocol, it was not
possible to blind the patients and/or the investigator who
performed the ES and physiotherapy.
3.3. Assessments
PROM and spasticity were assessed using a classical two-arm
goniometer. Themuscle tonewas assessed using themodiﬁed
Tardieu scale (MTS). This scale is considered to be best suited
for the measurement of spasticity as the resistance is
compared during stretches at different velocities [13]. Re-
search has shown that PROM and MTS have good to excellent
intrarater and interrater reliability (ranging from 74% to 90%
agreement rates between raters and measures) when asses-
sing ankle plantar ﬂexor spasticity in children with CP [14].
The muscle tone of the ankle plantar ﬂexors was assessed
in both knee ﬂexion and extension. Hamstring spasticity was
tested in a supine positionwith the pelvic-femoral angle to 908.
Two levels of the angle were measured after slow and fast
stretches of the joint, referring to R2 and R1 angle respectively.
R1 was deﬁned as the point in the PROM where a catch or
clonuswas ﬁrst felt during a quick stretch of the joint, while R2
was deﬁned as the total PROM of the ankle. R2-R1 represents
the dynamic component of spasticity. Spasticity was quanti-
ﬁed according to the quality of muscle reaction for grades 0–5
during the fast as possible stretch [13,14].
Gross motor abilities were assessed using the Gross Motor
Functions Measure, GMFM-88. The reliability of this test are
sufﬁcient (interrater reliability: intraclass correlation coefﬁ-
cient [ICC[113_TD$DIFF] = 0.75–1.00; test–retest reliability: ICC[114_TD$DIFF] = 0.96–0.99).
The GMFM-88 is responsive to changes in motor functioning
and can be used to measure changes in gross motor skills over
time in children with CP as well as evaluate physiotherapeutic
interventions for these children [15,16].
All ﬁve dimensionsweremeasured: A – lying and rolling (17
items); B – sitting (20 items); C – crawling and kneeling (14
items); D – standing (13 items); E – walking, running, jumping
(24 items). Each itemwas scored on 1–3 point scale. TheGMFM-
88 total score was calculated as the mean score of all 5
dimensions.
The Timed Up and Go (TUG) test was used to evaluate basic
mobility. Researchhas shown that theTUGhashigh reliability,
with ICC of 0.99 for within-session reliability and 0.99 for test–
retest reliability. This test is recommended as an outcome
measure in intervention studies for children with CP, a
measure of disability, and as ameasure of change in functional
mobility over time [17].
Participants were instructed to rise, walk as quickly and
safely as possible for [115_TD$DIFF]3 m, turn around, walk back to the chair,
and sit down on set cues. The fastest of 3 trials, measured to a
tenth of the second,was used to calculate themean score of all
5 dimensions (Table 1).The physiotherapists with expertise in pediatric develop-
mental rehabilitation performed all assessments. Measure-
ment sessions took place on the day of the start of the
treatment program, and between 1 and 2 days after the end of
treatment.
3.4. Analysis
Data analysis was performed using SPSS 22. Descriptive
statistics were used to describe characteristics of the partici-
pants in both study groups.
The repeated measures analysis of variance (ANOVA) was
used to compare GMFM, TUG, and PROM before and after
treatment in both study groups, and the one-way ANOVA was
used to determine differences in treatment effect between
groups. The differences betweenMTS taken at ﬁrst and second
assessment of the ES and control groups were compared by
using the Wilcoxon signed rank test for related samples and
Mann–Whitney U test for independent samples. A difference
was accepted as statistically signiﬁcant at p [116_TD$DIFF] < 0.05.
4. ResultsSixteen children were enrolled in the investigation, and all of
them completed the full 3 weeks treatment. Of the 16 children,
8 received ES with Mollii suit (i.e. Inerventions method) and 8
received conventional physiotherapy. The comparability of
the ES and the physiotherapy groups was assessed by
examining baseline measurements of all outcome measures,
includingGMFM, TUG, and the clinicalmeasurements of PROM
and MTS. There were no signiﬁcant clinical, functional and
demographic differences between the groups at baseline
(Table 1).
The Inerventions method had the positive impact on a
gross motor function of all children with CP (Table 1). Positive
changes in standing, walking, running and jumping dimen-
sions were registered by GMFM test. The mean change in
GMFM in the ES group was 3.38% (F[117_TD$DIFF] = 16.715; p = 0.005) and in
the physiotherapy group 2.81% (F[118_TD$DIFF] = 17.257; p = 0.004). Howev-
er, the difference in mean GMFM improvement between CP
children treated with the Inerventions method and conven-
tional physiotherapy was non-signiﬁcant, F [119_TD$DIFF] = 0.25, p = 0.63.
After the ES treatment, all patients also experienced
improvement in mobility (Table 1). The improvement of
TUG scores ranged from 0.14 to 9.24 (mean 2.244, SD[120_TD$DIFF] = 2.967)
sec. in the ES group (F [121_TD$DIFF] = 7.177; p = 0.032). The improvement of
TUG scores in the physiotherapy group ranged from 0.11 to
3.41 (mean 1.885, SD[122_TD$DIFF] = 0.961) s (F = 30.971; p = 0.001).
We found no meaningful change in PROM as well as
spasticity of the ankle plantar ﬂexors and hamstrings in both
experimental and control groups (Table 1).
No adverse effects were noted with the Inerventions
treatment.
5. DiscussionThe Inerventions method is the innovative ES method using
the sub-threshold sensory ES to cause reciprocal inhibition of
Table 1 –Mean baseline values and mean change between values at baseline and first week after treatment for all outcome
measures in both ES and non-ES groups.
Values at baseline (mean, SD) Values after the end of treatment
(mean, SD)
Differences in treatment
effect between groups
ES Non-ES ES Non-ES Mean=
SD=
GMFM score (%) Mean [88_TD$DIFF] = 79.77
SD = 10.81
Mean = 84.6
SD = 8.32
F = 0.21
p = 0.33
Mean = 82.42
SD = 10.62
Mean = 86.87
SD = 7.41
F = 0.95
p = 0.35
Mean = 2.43
SD = 1.63
F = 0.25
p = 0.63
TUG (s) Mean [89_TD$DIFF] = 17.23
SD = 6.10
Mean = 15.52
SD = 3.06
F = 0.5
p = 0.49
Mean = 14.99
SD = 4.50
Mean = 13.63
SD = 2.52
F = 0.47
p = 0.51
Mean = 2.07
SD = 2.14
F = 27
p = 0.75
Spasticity (Tardieu scale)
L knee ﬂexors Mean [90_TD$DIFF] = 1.66
SD = 0.51
Mean = 1.5
SD = 0.57
U = 10
p = 0.76
Mean = 1.66
SD = 0.51
Mean = 1.2
SD = 0.83
U = 10
p = 0.42
Mean = 0.01
SD = 0
U = 14
p = 1
R knee ﬂexors Mean [91_TD$DIFF] = 2.1
SD = 0.52
Mean = 1.83
SD = 0.41
U = 15
p = 0.69
Mean = 1.66
SD = 0.51
Mean = 1.66
SD = 0.51
U = 18
p = 1
Mean = 0.25
SD = 0.45
U = 14
p = 0.89
Extended knee
L ankle plantaﬂexors Mean [92_TD$DIFF] = 2.1
SD = 0.52
Mean = 2.5
SD = 0.57
U = 6
p = 0.25
Mean = 1.83
SD = 0.41
Mean = 2.25
SD = 0.5
U = 7.5
p = 0.35
Mean = 1.66 SD = 2.5 U = 12.5
p = 0.67
R ankle plantar ﬂexors Mean [93_TD$DIFF] = 1.83
SD = 0.41
Mean = 2.33
SD = 0.51
U = 7.5
p = 0.35
Mean = 1.83
SD = 0.75
Mean = 1.83
SD = 0.41
U = 9
p = 0.61
Mean = 0.5
SD = 0.52
U = 18
p = 1
Flexed knee
L ankle plantar ﬂexors Mean [94_TD$DIFF] = 1.83
SD = 0.75
Mean = 2.5
SD = 0.57
U = 6
p = 0.25
Mean = 1.5
SD = 0.54
Mean = 1.75
SD = 0.5
U = 9
p = 0.61
Mean = 0.5
SD = 0.52
U = 7
p = 0.22
R ankle plantar ﬂexors Mean [95_TD$DIFF] = 1.83
SD = 0.41
Mean = 2.1
SD = 0.41
U = 12.5
p = 0.39
Mean = 1.83
SD = 0.41
Mean = 1.83
SD = 0.41
U = 18
p = 1
Mean = 0.16
SD = 0.38
U = 12
p = 0.13
PROM (degrees)
L knee extension Mean [96_TD$DIFF] = 53.33
SD = 11.25
Mean = 60
SD = 10.8
F = 0.868
p = 0.379
Mean = 48.33
SD = 16.32
Mean = 55
SD = 17.32
F = 0.382
p = 0.055
Mean = 4.01
SD = 6.14
F = 0.0001
p = 1
R knee extension Mean [97_TD$DIFF] = 58.33
SD = 11.69
Mean = 60.83
SD = 5.8
F = 0.22
p = 0.649
Mean = 55
SD = 13.03
Mean = 60
SD = 5.47
F = 0.75
p = 0.407
Mean = 1.25
SD = 2.26
F = 1.8
p = 0.209
Flexed knee
L ankle dorsiﬂexion Mean [98_TD$DIFF] = 7.5
SD = 14.40
Mean = –6.25
SD = 14.93
F = 2.127
p = 0.183
Mean = 9.16
SD = 14.97
Mean = –3.7
SD = 15.47
F = 1.741
p = 0.223
Mean = 2.5
SD = 2.63
F = 0.229
p = 0.645
R ankle dorsiﬂexion Mean [99_TD$DIFF] = 2
SD = 8.2
Mean = 2.83
SD = 13.93
F = 0.16
p = 0.901
Mean = 6.66
SD = 8.16
Mean = 5
SD = 15.49
F = 0.54.5
p = 0.82
Mean = 4.25
SD = 3.51
F = 1.301
p = 0.281
Extended knee
L ankle dorsiﬂexion Mean [100_TD$DIFF] = 4.285
SD = 9.83
Mean = –1.25
SD = 8.53
F = 0.747
p = 0.41
Mean = 5.714
SD = 12.90
Mean = 1.25
SD = 6.29
F = 0.461
p = 0.514
Mean = 1.66
SD = 2.5
F = 0.433
p = 0.527
R ankle dorsiﬂexion Mean [101_TD$DIFF] = 2.33
SD = 7.39
Mean = 1.5
SD = 7.96
F = 0.35
p = 0.855
Mean = 5
SD = 7.74
Mean = 2.5
SD = 6.12
F = 0.385
p = 0.549
Mean = 2.2, SD = 2.44 F = 0.001
p = 1
GMFM, Gross Motor Function Measure; ES, experimental group; non-ES, control group; L, left; PROM, passive range of motion; R, right; TUG,
Timed Up and Go test.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 5 8 1 – 5 8 6584themuscles. Themanufacturers claim that ES usingMollii suit
improves muscle tone, range, control and movement and
therefore differs from others TES and FES ES devices [11].
There are only a few studies that have investigated the use
of the Mollii suit for children with CP. Auer (2009) has
evaluated the combination of Conductive Education (i.e. the
educational system to assist children in developing the ability
to conduct activities of daily living) and the Interventions
method for 24 children with CP. Investigators, as well as
parents of children, noted positive effects of the suit, such as
the reduction of spasticity, better mobility and everyday
functioning [18]. Shi et al. (2012) evaluated the cost-effective-
ness of Inerventions method and compared it with conven-
tional medical treatments, e.g. baclofen, botulinum toxin,
surgery, for children with CP in Sweden. This pilot study
suggested the superior cost-effectiveness of the Inerventions
method [19]. Westerlund et al. (2014) conducted a survey toexplore experiences of patients who have used the Inerven-
tions method for the treatment of various neurological
conditions including CP. Up to 90% of patients in the study
indicated an overall improvement of general condition. The
most pronounced effect was felt on locomotion, general
spasticity, the range of movements, such as hand/ﬁnger
extension, raising the arm above head, placing heel on the
ground [11]. None of the studies that investigated beneﬁts of
the Inerventions method for CP were published in peer-
reviewed journals, and all of them share serious methodologi-
cal limitations, such as a small or heterogeneous sample size,
non-comparative observational study design, non-validated
outcome measures, incomplete or/and inaccurate reporting.
The present study aimed to compare the effects of the
Inerventions method and conventional physiotherapy on
motor function in children with CP. To the best of our
knowledge, this is the ﬁrst independent comparative
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The muscles selected for ES were the rectus femoris and
tibialis anterior. These muscles are very important for
functional gross motor skills. The rectus femoris ﬂexes the
hip joint and extends the knee, and thus, together with other
vasti muscles support body weight during standing and
walking. The tibialis anterior, the main ankle dorsal ﬂexors,
prevents drop foot during the swing phase of gait. It was
hypothesised that, since the Inerventions method decreases
muscle hyperactivity (i.e. spasticity and muscle co-contrac-
tion), the children's motor function and mobility might
improve following the treatment because of an expected
increase in the range of motion as well as improvement in
selective voluntary control. Results indicated that the effect of
ES varied from one subject to the other. Nevertheless, mild
improvement in grossmotor abilities andmobility occurred as
reﬂected by positive changes in GMFM and TUG test. The
Inerventions method and conventional physiotherapy
appeared to have similar effects on gross motor function
andmobility. Neither ES nor physiotherapy affected spasticity
and PROM.
Previous studies analysing the effect of TES on gross motor
function for children with CP provided rather conﬂicting
results. Pape et al. (1993) followed the development of 38
children treatedwith TES for one year. The investigators found
positive effects of TES, including the growth of the quadriceps,
better motor performance and results in the Peabody
Developmental Motor Scale [5]. Steinbok et al. (1997) carried
out a randomized control trial to determine the effectiveness
of TES in improving the function of children with CP who have
undergone selective dorsal rhizotomy and described the
signiﬁcant improvement in the GMFM for TES-treated chil-
dren. Similar to ours, the study found no positive effects of TES
on strength, spasticity, or PROM for children with CP [7]. In
addition, the paper from Liron-Keshet et al. (2001) claimed that
TES delivered to the quadriceps and dorsiﬂexors improved
overall gait quality and range of motion for children with
spastic diplegia [8].
In contrast, other investigators did not ﬁnd a signiﬁcant
difference in TES–placebo effects. Hazlewood et al. (1994)
revealed no changes in gait for 10 children with hemiplegic CP
who received ES of the anterior tibial muscle daily for an hour
for 35 days [6]. The crossover-study from Sommerfelt et al.
(2001) also did not ﬁnd any signiﬁcant effect of TES on amotor
and ambulatory function for 12 children with diplegic CP [9].
Finally, Dali et al. (2002) conducted a randomized double-blind
placebo-controlled clinical trial to determine whether a group
of 57 childrenwith CPwould improve theirmotor skills after 12
months of TES. Results of the study showed that ES didn't
affect motor function, ROM or muscle size [10].
Inconsistent results obtained in previous studies may be
due to different ES or/and treatment characteristics (e.g.
frequency, amplitude, a number of sessions, treatment
intervals). Moreover, the methodological limitations such as
small sample size, non-validated outcome measure, and
uncontrolled study design could inﬂuence the results and
conclusions of the above-mentioned studies.
Our study also has some limitations which have to be
pointed out. Despite the comprehensive assessment of
treatment outcomes, the expected statistical power is limiteddue to the rather small number of participants. It is also
conceivable that a more intensive ES would have resulted in
more signiﬁcant changes related to gross motor function.
Manufacturers do not provide any recommendations for
optimal length of treatment with Mollii suit except the
statement that ES using the Mollii suit reduce muscle
spasticity and improve movement for up to [123_TD$DIFF][124_TD$DIFF] 8 h after each
session while with regular use the effects may be extended
beyond 48 h [20]. Based on this assertion we have decided that
the 3-week treatment duration would be enough to see the
difference. Moreover, a combination of the Inerventions
method and physiotherapy could be more effective than
using either of these treatments alone. Further studies,
employing large sample sizes, extending the period of
intervention, also comparing different treatment strategies
(e. g., ES plus physiotherapy versus physiotherapy alone) are
required to provide conclusive evidence for or against the
Inerventions method.
6. Clinical implications/future directionsThe Inerventions method has been shown to have the mild
positive effect onmobility andmotor function in childrenwith
spastic CP. However, there is no evidence for the superior
efﬁcacy of the Inerventionsmethod compared to conventional
physiotherapy. Nor the Inerventions method neither conven-
tional therapy did not affect PROM nor degree of spasticity.
Further studies are indicated to establish whether or not the
Inerventions method cause improvement in children with
spastic CP.
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